Quantinno Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Other funds holding CLDX
KCM
BBA
Quantinno Capital Management's CLDX Position: Q3 2026 in Review
Quantinno Capital Management increased its Celldex Therapeutics (CLDX) stake by 85% in Q3 2026, buying an estimated $2.23M and bringing the position to 127,400 shares worth $4.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1596.
Quantinno Capital Management first reported a position in CLDX in Q4 2025 and has held it in 4 quarters since. 249 funds tracked by Wall St. Rank hold CLDX as of Q3 2026.
- Quantinno Capital Management held 127,400 shares of Celldex Therapeutics worth $4.13M as of Q3 2026.
- Quantinno Capital Management bought 58,352 Celldex Therapeutics shares in Q3 2026, an estimated $2.23M.
- Celldex Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1596 holding.
- Quantinno Capital Management first reported a position in Celldex Therapeutics in Q4 2025 and has held it in 4 quarters since.
- 249 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.